Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Insilico Biotechnology
Insilico Biotechnology
Activities:
Ingredients
Pharmaceutical
X
LinkedIn
Trending Articles
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme
AI-driven approach promises a new class of depression treatment
IMA Ilapak Doytronic 120 wins Oscar de l’Emballage 2024 award
Innovative stand-up pouch machine recognised for primary packaging excellence
You need to be a subscriber to read this article.
Click here
to find out more.
Creating a framework to measure the impact of drug delivery devices
Alex Fong, Insights and Sustainability Lead at Owen Mumford, discusses the company’s lifecycle assessment (LCA) journey
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Manufacturing
Yokogawa acquires bioprocessing digital twin expert
The company has acquired Insilico Biotechnology to build its biopharma offering
Finance
Insilico and 2-control work towards the smart biofactory
The agreement follows Insilico's previous collaboration with Meyer Chroma Technology
Manufacturing
Insilico Biotechnology moves into the US predictive twin market
Insilico Biotechnology has announced the opening of its first subsidiary in the US, located in Boston, Massachusetts
Manufacturing
Insilico and Janssen take another step towards predictive biomanufacturing
The digital twins collaboration will run for three years and will be based at Insilico's site in Stuttgart, Germany and at Janssen's Spring House location in the US
Manufacturing
Insilico works with university on digital twins for antibody production
The German collaboration aims to enable true online-control of critical quality attributes such as the glycosylation profile
Subscribe now